Literature DB >> 7686392

CD28-B7 interactions are not required for intrathymic clonal deletion.

L A Jones1, D J Izon, J D Nieland, P S Linsley, A M Kruisbeek.   

Abstract

Activation of antigen specific T cells requires more than stimulation through the TCR-CD3 complex. A second or costimulatory signal is also required, and this second signal can be delivered by interactions between CD28 and B7, ligands expressed on T cells and antigen presenting cells respectively. We have examined the role of the CD28-B7 interaction in superantigen mediated T cell activation and intrathymic negative selection by blocking B7 molecules with a high affinity soluble ligand, CTLA4lg. In vitro T cell activation mediated by both virally encoded endogenous and exogenous bacterial superantigens was significantly blocked by the addition of CTL4Alg to cultures. However, intrathymic clonal deletion in vivo and in fetal thymic organ cultures was not inhibited by blocking B7 molecules. Therefore, although the CD28-B7 costimulation pathway is necessary for T cell activation, it does not appear to play a role in intrathymic clonal deletion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686392     DOI: 10.1093/intimm/5.5.503

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

1.  Thymocyte development is normal in CTLA-4-deficient mice.

Authors:  C A Chambers; D Cado; T Truong; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  Enhancement of CD3-mediated thymocyte apoptosis by the cross-linkage of heat-stable antigen.

Authors:  Y Hitsumoto; D S Song; M Okada; F Hamada; S Saheki; N Takeuchi
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

3.  Divergent effects of T cell costimulation and inflammatory cytokine production on autoimmune peripheral neuropathy provoked by Aire deficiency.

Authors:  Xiaopei L Zeng; Anil Nagavalli; Colin-Jamal Smith; James F Howard; Maureen A Su
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

4.  Clonal deletion and the fate of autoreactive thymocytes that survive negative selection.

Authors:  Leonid A Pobezinsky; Georgi S Angelov; Xuguang Tai; Susanna Jeurling; François Van Laethem; Lionel Feigenbaum; Jung-Hyun Park; Alfred Singer
Journal:  Nat Immunol       Date:  2012-04-29       Impact factor: 25.606

5.  T cell receptor (TCR)-induced death of immature CD4+CD8+ thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus.

Authors:  J A Punt; W Havran; R Abe; A Sarin; A Singer
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

6.  Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment.

Authors:  B F Haynes; C S Heinly
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

7.  The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes.

Authors:  M Rincón; A Whitmarsh; D D Yang; L Weiss; B Dérijard; P Jayaraj; R J Davis; R A Flavell
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

8.  Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28.

Authors:  J A Punt; B A Osborne; Y Takahama; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

9.  An essential role for gp39, the ligand for CD40, in thymic selection.

Authors:  T M Foy; D M Page; T J Waldschmidt; A Schoneveld; J D Laman; S R Masters; L Tygrett; J A Ledbetter; A Aruffo; E Claassen; J C Xu; R A Flavell; S Oehen; S M Hedrick; R J Noelle
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo.

Authors:  F Ronchese; B Hausmann; S Hubele; P Lane
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.